| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.18 | 8e-08 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-06 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.2 | 4e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-06 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.23 | 4e-05 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.41 | 6e-05 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |